ACETAMINOPHENASSAY

European patent · EP3813812 · In force

Register entry

Publication number
EP3813812
Application number
EP19797109
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 3, 2019
Published
May 5, 2021
Granted
Dec 3, 2025
Protection ends at the latest
May 2, 2039
Next annual fee due
May 31, 2027
IPC classes
A61K 31/167 (2006.01)
C12Q 1/34 (2006.01)
G01N 21/78 (2006.01)
G01N 33/52 (2006.01)
G01N 33/53 (2006.01)
G01N 33/58 (2006.01)
Priority
US 201862666282 P 03.05.2018
PCT application
PCT/US2019/030558 03.05.2019
PCT publication
WO2019/213489 07.11.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 14, 2026

    Change

    Published in Swissreg on 14.10.2026

  2. Jun 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. Dec 5, 2025

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 05.12.2025

  4. Dec 3, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.12.2025

Parties

Holder

Sekisui Diagnostics, LLC

One Wall Street, Burlington, MA 01803, US

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

ACORN, Robert

Charlottetown, PE, C1E 2B9, CA

COADY, Helen

Charlottetown, PE, C1E 2B9, CA

COLL, Graham

Charlottetown, PE, C1E 2B9, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.